Cleared Traditional

K844313 - INFUSET W/HUBER NEEDLE

K844313 is an FDA 510(k) clearance for INFUSET W/HUBER NEEDLE, manufactured by Med Fusion Systems, Inc.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 77-day FDA review.

K844313 · Med Fusion Systems, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1985
Decision
77d
Days
Class 2
Risk

K844313 is an FDA 510(k) clearance for the INFUSET W/HUBER NEEDLE. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Med Fusion Systems, Inc. (Marietta, US). The FDA issued a Cleared decision on January 22, 1985 after a review of 77 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Med Fusion Systems, Inc. devices

FDA 510(k) Submission Details - K844313

510(k) Number K844313 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 1984
Decision Date January 22, 1985
Days to Decision 77 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 129d · This submission: 77d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 480
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K844313.
VASCULAR IMPLANT ACCESS NEEDLE SET
K851103 · Baxter Healthcare Corp · Jul 1985
JMS NEEDLES & JMS SYRINGES
K845043 · Jms Co., Ltd. · Apr 1985
CHURCHILL HABER POINT NEEDLE ADMIN. SET
K850420 · Churchill Corp. · Apr 1985
MONOJECT MENGHINI SOFT TISSUE BIOPSY
K843264 · Sherwood Medical Co. · Dec 1984
AMER. PHARMASEAL CHEMONUCLEOLYSIS TRAY
K842542 · American Pharmaseal Div. Ahsc · Aug 1984
UMI CURVED CHEMONUCLEOLYSIS NEEDLE
K842012 · Universal Medical Instrument Corp. · Jul 1984